T1	HMM 355 374	safety and efficacy
T2	HMM 1028 1182	primary end point was noninferiority of 9-month target vessel failure defined as cardiac death, myocardial infarction, or target vessel revascularization.
T3	HMM 1321 1342	target vessel failure
T4	HMM 1425 1462	periprocedural myocardial infarctions
T5	HMM 1587 1678	cardiac death, myocardial infarction, target vessel revascularization, or stent thrombosis.
T6	HMM 1709 1750	binary angiographic in-segment restenosis
T7	HMM 1850 1881	target lesion revascularization
